discoveri
new
antimicrobi
molecul
earli
landmark
field
pharmacolog
allow
reduct
morbid
mortal
infecti
diseas
among
main
caus
death
worldwid
howev
widespread
indiscrimin
use
power
antibiot
recent
decad
led
dramat
increas
microbi
resist
nowaday
major
threat
global
public
health
long
list
identifi
drugresist
bacteria
includ
sulfonamideresist
penicillinresist
methicillinresist
macrolideresist
vancomycinresist
even
multidrugresist
result
drugresist
bacteri
infect
result
need
use
higher
drug
dosag
higher
toxic
treatment
longer
hospit
period
ultim
translat
increas
mortal
thu
neg
affect
medicin
societi
antimicrobi
resist
nowaday
one
major
global
econom
healthcar
burden
despit
effort
research
develop
new
molecular
entiti
pipelin
new
drug
tend
grow
empti
bacteriocin
peptid
produc
mainli
gramposit
bacteria
main
purpos
selfpreserv
larg
portion
gramneg
bacteriocin
resembl
eukaryot
antimicrobi
peptid
defensin
antimicrobi
peptid
depict
amphiphil
helic
differ
among
mode
action
biochem
properti
thu
spectrum
activ
classifi
accord
host
produc
intrins
function
molecular
weight
physicochem
properti
amino
acid
sequenc
mead
et
al
publish
comprehens
analysi
classif
use
multidrugresist
speci
antimicrobi
peptid
amp
small
peptidebas
molecul
amino
acid
length
potent
broadspectrum
antimicrobi
properti
amp
consid
among
promis
drug
candid
use
infect
aim
overcom
microbi
drug
resist
howev
also
display
limit
regard
bioavail
safeti
may
possess
addit
biolog
activ
function
amp
inde
use
signal
molecul
tissu
regener
biomark
even
tumoricid
agent
amp
produc
nearli
live
organ
act
bind
genet
materi
interact
cell
wall
cell
membran
andor
intracellular
organel
act
protect
plant
fungal
bacteri
invas
invertebr
vertebr
also
activ
parasit
viral
invas
may
induc
toxic
event
host
eukaryot
cell
tabl
summar
main
mechanist
pathway
mechan
action
amp
yet
fulli
describ
known
amp
receptormedi
nonreceptormedi
interact
cell
membran
amp
produc
bacteria
undergo
receptormedi
interact
activ
vitro
low
concentr
howev
vertebr
invertebr
amp
target
membran
without
specif
interact
receptor
activ
concentr
micromolar
rang
interact
compon
membran
ie
neg
charg
lipid
eg
lipopolysaccharid
cardiolipin
attract
posit
charg
amp
amp
may
target
bacteri
cell
wall
inhibit
cell
wall
synthesi
intracellular
target
convent
antibiot
compromis
synthesi
cell
wall
compon
bind
specif
protein
involv
reaction
amp
often
interact
precursor
molecul
need
synthesi
cell
wall
amp
produc
sever
immun
cell
eg
macrophag
neutrophil
peptid
also
activ
immun
cell
may
result
increas
microbi
kill
andor
control
inflamm
amp
also
act
deliveri
system
altern
convent
antibiot
particular
nosocomi
infect
caus
multidrug
resist
gramneg
pathogen
burrer
et
al
use
sever
strain
murin
coronaviru
cell
cultur
vivo
mous
model
assess
antivir
properti
peptideconjug
antisens
phosphorodiamid
morpholino
oligom
ppmo
author
report
target
effect
ppmo
variou
target
site
viral
genom
cell
cultur
protect
mice
virusinduc
tissu
damag
ykeda
et
al
use
antimicrobi
peptid
isol
skin
xenopu
tropicali
modifi
peptid
produc
selfassembl
discoid
nanoparticl
compos
amphiphil
alphahel
scaffold
protein
peptid
organis
lipid
bilay
peptid
hydrophob
hydrophil
face
behav
like
gener
surfact
use
carrier
bacteriocin
activ
low
concentr
usual
low
vivo
stabil
suscept
degrad
proteolyt
enzym
anoth
major
limit
use
peptid
difficulti
encount
largescal
product
compromis
altogeth
clinic
applic
approach
overcom
limit
stabil
vivo
load
nanoparticl
nanomedicin
current
wellestablish
approach
intim
relat
design
develop
nanomateri
uniqu
therapeut
diagnost
properti
nanotechnolog
also
shown
great
potenti
almost
everi
aspect
manag
microbi
infect
ten
nanoparticl
np
base
product
market
bacteri
diagnosi
antibiot
deliveri
medic
devic
uniqu
physicochem
characterist
nanomateri
sensit
select
detect
bacteri
signal
may
also
exbibit
intrins
antimicrobi
properti
furthermor
nanomateri
use
antimicrobi
drug
deliveri
incorpor
antimicrobi
nanomateri
medic
devic
implant
prevent
microbi
adhes
infect
fact
instrument
antimicrobi
resist
compromis
bacteri
mechan
resist
focus
nanomaterialsbas
drug
deliveri
system
offer
improv
strategi
increas
therapeut
index
decreas
dosag
frequenc
administr
besid
nanomateri
promot
intracellular
drug
deliveri
mitig
develop
drugresist
bacteria
also
allow
target
organ
accumul
function
surfac
modif
thu
limit
system
side
effect
immunosuppress
despit
promis
outcom
main
challeng
establish
clinic
use
relat
evalu
interact
nanoantibiot
cell
tissu
organ
achiev
inform
possibl
toxic
effect
togeth
product
larg
scale
sever
type
nanomateri
shown
potenti
pharmaceut
field
also
studi
potenti
drug
carrier
applic
deliveri
amp
promis
antimicrobi
molecul
due
natur
physicochem
characterist
limit
bioavail
aim
work
revis
stateoftheart
approach
combin
advantag
design
new
drug
deliveri
system
improv
antimicrobi
bioavail
take
account
recent
develop
nanomateri
antimicrobi
peptid
deliveri
amp
small
natur
oligopeptid
recent
show
potenti
activ
antibiot
resist
mechan
due
abil
lyse
bacteri
membran
thu
provid
broadspectrum
effect
target
microorgan
virus
parasit
main
interest
properti
amp
abil
select
disrupt
bacteri
membran
without
affect
mammalian
cell
thu
safe
addit
amp
refer
literatur
hostdef
peptid
antiinflammatori
anticanc
activ
synthes
molecul
take
action
defenc
mechan
biolog
threat
live
organ
origin
discoveri
amp
date
back
first
half
centuri
dubo
extract
antimicrobi
agent
soil
bacillu
strain
proven
effect
mice
pneumococci
infect
extract
fraction
allow
identif
gramicidin
despit
system
toxic
gramicidin
shown
effect
topic
treatment
wound
ulcer
first
animalorigin
amp
report
defensin
isol
rabbit
leukocyt
nowaday
amp
describ
current
molecular
develop
consult
seri
databas
avail
web
tabl
includ
natur
identifi
molecul
well
peptidomimet
molecul
analogu
pharmacolog
design
thank
use
bioinformat
current
food
drug
administr
fda
approv
amp
wellestablish
use
includ
bacitracin
colistin
polymyxin
b
although
topic
administr
despit
lack
consensu
influenc
peptid
sequenc
biolog
activ
amp
common
characterist
seem
import
fairli
relat
antimicrobi
properti
main
one
primarili
charg
amp
cation
secondli
hydrophob
amphipath
influenc
solubl
profil
consequ
bioavail
associ
structur
characterist
also
main
physicochem
properti
also
taken
account
design
new
synthet
amp
compar
convent
antibiot
amp
demonstr
signific
advantag
potenc
board
spectrum
activ
well
addit
activ
modul
immun
system
respons
low
resist
rate
also
show
limit
impair
safe
therapeut
use
sensit
proteolysi
influenc
stabil
undefin
toxicolog
data
system
use
addit
cation
amphiphil
natur
lead
high
bind
serum
protein
parenter
administr
consequ
rapid
elimin
bloodstream
circul
accumul
reticuloendotheli
system
thu
result
toxic
effect
reduc
activ
overcom
limit
strategi
develop
maxim
proven
therapeut
potenti
amp
numer
method
obtain
amp
deliveri
system
amp
could
immobil
onto
varieti
materi
onto
varieti
surfac
still
retain
antibacteri
activ
also
amp
target
load
nanoparticul
system
select
deliveri
capac
includ
polym
liposom
hydrogel
nanospher
nanocapsul
carbon
nanotub
practic
exampl
strategi
studi
mishra
et
al
focus
develop
ampcoat
surfac
specif
immobil
lassioglossiniii
onto
siliconebas
cathet
activ
urinari
tract
infect
time
water
et
al
develop
possibl
encapsul
plectasin
cation
amp
polymer
np
evalu
efficaci
aureu
strain
bacteria
show
resist
antibiot
drug
varieti
mechan
moreov
develop
even
new
mechan
resist
result
simultan
develop
resist
sever
antibiot
class
creat
danger
multidrugresist
mdr
bacteri
strain
howev
bacteria
drugresist
mean
stop
respond
antibiot
occur
higher
concentr
greater
concern
case
acquir
resist
initi
suscept
popul
bacteria
becom
resist
antibacteri
agent
particular
antibiot
prolifer
spread
select
pressur
use
drug
one
approach
address
challeng
design
analogu
drug
alreadi
clinic
use
activ
resist
organ
howev
bacteria
constantli
succeed
develop
resist
mechan
new
antibiot
drug
well
analogu
nanotechnolog
offer
opportun
reexplor
biolog
properti
alreadi
known
antimicrobi
compound
antibiot
manipul
size
modifi
effect
combin
amp
nanomateri
new
avail
paper
index
web
scienc
total
combin
amp
nanoparticl
nanomateri
publish
last
year
rang
disciplin
figur
evid
collect
review
work
huh
kwon
pelgrift
friedman
brook
brook
diab
et
al
shimanovich
gedanken
clarifi
microbi
drug
resist
mechan
nanotechnolog
may
consid
tool
issu
develop
drug
resist
occur
least
three
step
acquisit
microb
resist
gene
ii
express
resist
gene
iii
select
microb
express
resist
gene
first
bacteria
acquir
resist
singl
multipl
drug
horizont
gene
transfer
transform
conjug
transduct
bacteria
also
acquir
resist
gene
spontan
mutat
exist
gene
mdr
acquir
bacteri
cell
alreadi
contain
one
type
drug
resist
gene
acquir
anoth
type
drug
resist
gene
second
respons
exposur
antimicrobi
drug
microb
express
resist
gene
third
resist
becom
widespread
select
microb
express
resist
gene
antimicrobi
drug
select
pressur
favour
resist
occur
whenev
microb
expos
drug
erad
either
microbicid
effect
drug
microbiostat
effect
drug
follow
kill
host
immun
system
schemat
represent
specif
mechan
antimicrobi
drug
resist
shown
figur
nanomateri
figur
either
show
antimicrobi
activ
elev
effect
safeti
antibiot
administr
call
nanoantibiot
capabl
control
infect
vitro
vivo
explor
demonstr
unlik
mani
antimicrobi
agent
current
use
clinic
antimicrobi
np
may
pose
direct
acut
advers
effect
although
potenti
toxic
upon
longterm
exposur
question
importantli
antimicrobi
np
tackl
multipl
biolog
pathway
found
broad
speci
microb
mani
concurr
mutat
would
occur
develop
resist
np
antimicrobi
activ
prepar
antimicrobi
np
could
costeffect
compar
antibiot
synthesi
furthermor
stabl
enough
longterm
storag
prolong
shelflif
addit
np
withstand
harsh
condit
hightemperatur
steril
convent
antibiot
inactiv
antibiot
deliveri
use
nanomateri
offer
multipl
advantag
control
rel
uniform
distribut
target
tissu
ii
improv
solubl
iii
sustain
control
releas
iv
improv
patientcompli
v
minim
side
effect
vi
enhanc
cellular
intern
research
gold
np
increas
thank
mani
advantag
eas
synthesi
conjug
biomolecul
capabl
maintain
structur
circul
improv
effect
bacteria
thu
demonstr
high
potenti
field
nanomedicin
even
begin
research
field
focus
possibl
exploit
gold
np
combin
laser
radiat
thu
significantli
reduc
bacteria
viabil
due
cell
lysi
mechan
disrupt
current
two
recent
studi
report
explor
use
au
nanostructur
amp
deliveri
photoluminesc
au
nanodot
aund
prepar
chen
et
al
aund
function
hybrid
ligand
antimicrobi
peptid
surfactin
sft
dt
aunp
ultrasmal
nd
size
nm
achiev
exhibit
highli
effici
antimicrobi
activ
photoluminesc
properti
stabil
well
antimicrobi
activ
nd
also
studi
shown
characterist
highli
depend
densiti
sft
au
nd
rel
sft
exhibit
greater
antimicrobi
activ
nonmultidrugresist
bacteria
also
multidrugresist
bacteria
minim
inhibitori
concentr
valu
much
lower
sft
author
consid
antimicrobi
activ
mainli
achiev
synergist
effect
sft
disrupt
bacteri
membran
vitro
cytotox
hemolysi
analys
also
perform
reveal
superior
biocompat
sft
moreov
vivo
methicillinresist
aureu
infect
wound
heal
studi
rat
show
faster
heal
better
epitheli
studi
suggest
system
may
promis
antimicrobi
candid
preclin
applic
treat
wound
skin
infect
rai
et
al
also
report
onestep
methodolog
gener
ampconjug
aunp
ampconjug
aunp
prepar
show
control
size
nm
low
polydispers
allow
inclus
high
concentr
amp
system
demonstr
higher
antimicrobi
activ
stabil
serum
presenc
nonphysiolog
concentr
proteolyt
enzym
solubl
amp
well
low
cytotox
human
cell
interestingli
akrami
et
al
show
possibl
exploit
gold
np
novel
anticanc
platform
result
research
confirm
improv
cell
intern
gold
np
higher
cytotox
cellular
uptak
smaller
np
compar
larger
nanospher
nanorod
suggest
anticanc
effect
select
peptid
modul
size
shape
gold
nanoparticl
geilich
et
al
develop
novel
deliveri
system
combin
silver
np
ampicillin
achiev
synergist
dosedepend
effect
bacteri
cell
obtain
polymersom
safe
human
fibroblast
effect
inhibit
bacteri
cell
silvertoampicillin
ratio
one
respect
recent
advanc
amp
deliveri
ag
nanostructur
pazo
et
al
report
supramolecular
assembl
novel
peptid
amphiphil
pa
contain
aldehyd
function
order
reduc
ag
ion
subsequ
nucleat
ag
metal
np
water
propos
system
spontan
gener
monodispers
ag
particl
regular
distanc
along
length
filament
organ
assembl
hybrid
structur
exhibit
antimicrobi
activ
significantli
less
toxic
toward
eukaryot
cell
metal
organ
nanofib
type
describ
offer
possibl
creat
structur
instanc
hydrogel
potenti
appli
wound
dress
develop
also
address
wound
infect
problem
salouti
et
al
investig
synergist
antibacteri
effect
plant
peptid
agnp
infect
wound
caus
aureu
mic
mbc
agnp
combin
form
determin
aureu
via
macrodilut
microdilut
method
mic
mbc
found
mgml
respect
mic
mbc
agnp
determin
mgl
respect
mic
mbc
agnp
combin
found
mgml
mgl
mgml
mgl
respect
synergist
antibacteri
effect
ag
np
investig
infect
wound
caus
aureu
mous
model
infect
wound
heal
properli
combin
use
agnp
worth
note
recent
find
chaudhari
et
al
concern
conjug
silverco
carbon
nanotub
antimicrobi
peptid
herein
author
underlin
occurr
addit
effect
silverco
nanotub
regard
antibacteri
activ
innov
nanosystem
found
safe
murin
macrophag
cell
mic
concentr
deliveri
system
amp
silicon
silicon
deriv
nanostructur
also
investig
recent
membran
interact
critic
success
use
mesopor
sinp
order
elucid
braun
et
al
studi
effect
np
charg
poros
amp
load
releas
well
consequ
membran
interact
antimicrobi
effect
anion
mesopor
sinp
found
incorpor
consider
amount
camp
wherea
load
found
much
lower
nonpor
posit
charg
sinp
result
also
demonstr
due
preferenti
pore
local
anion
mesopor
particl
particl
protect
degrad
infectionrel
proteas
anion
sinp
membran
disrupt
mediat
almost
exclus
peptid
releas
contrast
nonpor
sinp
built
resili
surfac
coat
due
higher
neg
surfac
charg
display
larg
particlemedi
membran
interact
antimicrobi
effect
posit
charg
mesopor
sinp
incorpor
promot
membran
bind
disrupt
display
particl
absenc
peptid
also
caus
toxic
human
erythrocyt
thu
use
mesopor
sinp
amp
deliveri
system
requir
consider
membran
interact
select
free
peptid
peptideload
np
properti
amp
adsorb
inorgan
organ
surfac
interest
potenti
applic
intracellular
drug
deliveri
work
syryamina
et
al
continuouswav
cw
electron
paramagnet
reson
epr
puls
electronelectron
doubl
reson
peldor
techniqu
appli
studi
adsorpt
amp
trichogin
ga
iv
ampullosporin
monodispers
colloid
silica
nanospher
sin
nm
diamet
result
obtain
cw
epr
support
view
adsorb
peptid
form
closepack
cluster
peldor
data
show
trichogin
ampullosporin
adsorb
silica
surfac
possess
disord
conform
compar
solut
ampullosporin
disord
much
pronounc
trichogin
desorpt
peptid
restor
conform
upon
adsorpt
peptid
case
may
lose
partli
birad
charact
result
may
interest
antimicrobi
activ
often
relat
peptid
conform
nanoclay
layer
silic
interest
nanostructur
use
remedi
environment
contamin
deliveri
drug
variou
activ
molecul
enhanc
polym
mechan
barrier
properti
packag
film
typic
present
stack
arrang
silic
layer
nanometr
thick
meira
et
al
studi
three
differ
nanoclay
bentonit
octadecylaminemodifi
montmorillonit
halloysit
potenti
carrier
amp
nisin
pediocin
known
bacteriocin
first
refer
applic
food
preserv
higher
adsorpt
room
temperatur
nisin
pediocin
obtain
bentonit
antimicrobi
activ
result
bacteriocinnanoclay
system
analys
use
skim
milk
agar
food
simul
largest
inhibit
zone
observ
gramposit
bacteria
halloysit
sampl
bacteriocin
intercal
interlay
space
montmorillonit
deduc
increas
basal
space
measur
xray
diffract
xrd
assay
result
indic
nanoclay
especi
halloysit
suitabl
nanocarri
nisin
pediocin
adsorpt
result
may
consid
interest
food
industri
differ
biodegrad
polymer
nanosystem
explor
carrier
antimicrobi
agent
exhibit
high
bactericid
activ
efficaci
strategi
well
proven
highlight
polymer
nanosystem
effect
improv
cellular
penetr
intracellular
retent
specif
subcellular
distribut
antimicrobi
agent
even
evad
intracellular
inactiv
antimicrobi
agent
control
drug
releas
use
biocompat
biodegrad
polym
emerg
first
polymerbas
deliveri
macromolecul
use
poli
ethylen
vinyl
acet
polym
demonstr
antimicrobi
drug
deliveri
use
polymer
np
offer
sever
advantag
structur
stabil
biolog
fluid
harsh
variou
condit
prepar
ii
precis
tuneabl
properti
size
zetapotenti
drug
releas
profil
manipul
polym
length
surfact
organ
solvent
use
np
prepar
iii
facil
versatil
surfac
function
conjug
drug
target
ligand
concern
antimicrobi
nanoparticul
deliveri
system
two
major
type
polym
explor
linear
polym
eg
polyalkyl
acryl
polymethyl
methacryl
amphiphil
block
copolym
major
polymer
np
prepar
linear
polym
nanocapsul
solid
nanospher
polymer
nanocapsul
polymer
membran
control
releas
rate
surround
drug
solubil
aqueou
oili
solvent
solid
nanospher
drug
homogen
distribut
polymer
matric
variabl
poros
amphiphil
block
copolym
form
selfassembl
micellar
np
drug
encapsul
hydrophob
core
surround
hydrophil
shield
shi
allow
core
protect
degrad
sever
biodegrad
polym
includ
poli
lactic
acid
pla
poli
glycol
acid
pga
poli
lactidecoglycolid
plga
poli
caprolacton
pcl
poli
cyanoacryl
pca
use
hydrophob
core
amphiphil
copolym
wherea
peg
commonli
use
hydrophil
segment
target
ligand
also
conjug
termini
peg
target
select
deliveri
polymer
np
explor
deliv
variou
antimicrobi
agent
greatli
enhanc
therapeut
efficaci
treat
mani
type
infecti
diseas
report
instanc
encapsul
ampicillin
polymer
np
effect
typhimurium
infect
treatment
intracellular
l
monocytogen
infect
mous
periton
macrophag
use
polymer
np
overcom
limit
oral
administr
unstabl
inadequ
absorb
drug
addit
pegyl
np
increas
drug
halflif
serum
improv
mucoadhes
capabl
reduc
phagocytosi
thu
among
nanoparticl
platform
polym
np
may
suitabl
system
use
antimicrobi
drug
deliveri
biodegrad
polym
bioorgan
polym
also
promis
materi
deliveri
peptidebas
drug
due
compat
degrad
behaviour
nontox
natur
administr
develop
polymer
therapeut
nanostructur
amp
deliveri
may
offer
excel
technolog
strategi
improv
drug
bioavail
safeti
csbase
np
csnp
particularli
interest
broad
spectrum
antibacteri
activ
cs
well
known
document
offer
possibl
synergist
effect
antimicrobi
molecul
moreov
due
biocompat
properti
cs
nanostructur
extens
studi
drug
deliveri
differ
amp
deliveri
fact
major
studi
perform
far
involv
cs
nanostructur
alreadi
revis
previou
work
reproduc
tabl
research
cover
technolog
develop
new
carrier
system
full
character
evalu
efficaci
drug
deliveri
improv
addit
csbase
nanostructur
recent
studi
polymer
nanostructur
amp
deliveri
develop
tabl
angelo
et
al
design
develop
system
nanoembed
microparticl
nem
sustain
deliveri
cation
amp
camp
lung
studi
effect
p
aeruginosa
known
lung
infect
pathogen
purpos
plga
np
contain
model
camp
colistin
col
produc
emulsionsolv
diffus
techniqu
spraydri
differ
carrier
lactos
mannitol
thu
produc
nem
promis
nem
formul
select
bulk
flow
properti
distribut
np
carrier
aerosol
perform
upon
deliveri
breathactu
dri
powder
inhal
nem
found
kill
p
aeruginosa
biofilm
display
prolong
efficaci
compar
free
col
anoth
camp
plectasin
encapsul
plga
np
use
doubl
emuls
solvent
evapor
method
work
water
et
al
plectasinload
np
display
high
encapsul
effici
mediat
releas
peptid
h
antimicrobi
efficaci
investig
use
bronchial
epitheli
cell
monolay
infect
aureu
encapsul
plectasin
display
improv
efficaci
compar
nonencapsul
plectasin
author
also
assess
subcellular
local
prepar
np
differ
relev
cell
line
epitheli
cell
macrophag
epitheli
cell
result
shown
good
pattern
penetr
epitheli
cell
line
well
macrophag
hydrogel
nanogel
import
class
biomateri
wide
util
varieti
biomedicalmed
applic
biolog
perform
system
particularli
use
wound
dress
complement
antimicrobi
activ
capabl
prevent
colon
wound
site
opportunist
bacteri
pathogen
type
structur
also
studi
recent
amp
deliveri
continu
studi
antimicrobi
activ
multidomain
camp
mdcamp
solut
jiang
et
al
investig
effect
selfassembl
hydrogel
supramolecular
nanostructur
rheolog
properti
among
studi
mdcamp
solut
bactericid
activ
peptid
hydrogel
found
improv
improv
antimicrobi
activ
selfassembl
peptid
hydrogel
found
relat
combin
effect
supramolecular
surfac
chemistri
storag
modulu
bulk
materi
rather
abil
individu
peptidespeptid
assembl
penetr
bacteri
cell
membran
observ
solut
thu
relationship
develop
studi
may
provid
import
knowledg
design
biocompat
peptid
hydrogel
builtin
antimicrobi
activ
variou
biomed
applic
water
et
al
group
also
design
novel
nanogelbas
novicidin
deliveri
system
peptid
novicidin
selfassembl
nanoctenyl
succin
anhydridemodifi
analogu
hyaluron
acid
formul
optim
use
microfluidicsbas
qualitybydesign
approach
encapsul
effici
novicidin
zeta
potenti
mv
nanogel
could
tailor
chang
prepar
process
paramet
maximum
peptid
load
nanogel
exhibit
good
colloid
stabil
differ
ionic
strength
condit
allow
complet
releas
peptid
day
furthermor
selfassembl
novicidin
hyaluron
acid
nanogel
significantli
improv
safeti
profil
least
fivefold
sixfold
test
huvec
nih
cell
respect
show
loss
antimicrobi
activ
e
coli
aureu
li
et
al
explor
potenti
applic
amp
wound
heal
develop
biodegrad
poli
llactic
acid
pluron
llactic
acid
situ
gelform
system
inject
formul
compos
human
amp
load
np
thermosensit
hydrogel
prepar
peptid
enclos
biocompat
np
high
drug
load
encapsul
effici
encapsul
thermosensit
hydrogel
facilit
applic
cutan
wound
repair
result
releas
extend
period
exhibit
quit
low
cytotox
high
antioxid
activ
vitro
vivo
wound
heal
assay
use
fullthick
dermal
defect
model
sd
rat
indic
could
significantli
promot
wound
heal
day
oper
treat
group
show
nearli
complet
wound
closur
studi
nisin
nanoencapsul
perform
purpos
protect
ensur
stabil
amp
food
process
storag
period
nisinload
pectin
np
nlpnp
prepar
analys
krivirotova
et
al
simpl
complex
method
three
type
pectin
biopolym
test
found
methoxyl
degre
pectin
influenc
nisin
load
effici
particl
size
complex
format
electrostat
hydrophob
interact
import
nlpnp
exhibit
antimicrobi
activ
depend
type
biopolym
overal
result
indic
nlpnp
might
suitabl
antimicrobi
system
use
food
industri
nisin
nanoencapsul
selfassembl
chitosan
poli
glutam
acid
recent
report
wu
et
al
herein
author
show
use
coat
layer
chitosan
improv
colloid
stabil
load
capac
encapsul
effici
furthermor
chitosan
layer
composit
nanoparticl
effect
compar
uncoat
np
nisin
inhibit
growth
escherichia
coli
listeria
monocytogen
solid
lipid
nanoparticl
sln
nanostructur
lipid
carrier
nlc
stand
nanoparticl
compos
lipid
materi
melt
temperatur
main
purpos
modifi
releas
profil
payload
attribut
solid
core
sln
compos
solid
lipid
nlc
matrix
blend
solid
liquid
lipid
also
melt
bodi
temperatur
improv
solubl
lipophil
compound
sln
nlc
biodegrad
nontox
versatil
also
attribut
capac
load
rang
chemic
differ
bioactiv
includ
peptid
protein
modifi
surfac
fumakia
et
al
develop
sln
simultan
deliveri
endogen
host
defenc
peptid
antimicrobi
activ
elastas
inhibitor
serpin
treatment
wound
infect
author
report
sln
could
modifi
releas
profil
simultan
deliveri
bioactiv
acceler
wound
heal
bj
fibroblast
cell
keratinocyt
promot
antibacteri
activ
staphylococcu
aureu
escherichia
coli
comparison
alon
load
nlc
also
propos
garciaoru
topic
treatment
chronic
wound
nlc
affect
cell
viabil
test
human
foreskin
fibroblast
vitro
bioactiv
assay
show
peptid
remain
activ
load
lipid
nanoparticl
system
revers
macrophag
activ
happen
solut
nlc
also
activ
escherichia
coli
vivo
test
mice
also
demonstr
system
capac
improv
heal
promot
wound
closur
reepithel
grade
restor
inflammatori
process
lewi
et
al
demonstr
biodegrad
nlc
enhanc
antibacteri
activ
antimicrobi
peptid
author
studi
effect
nisin
z
load
nanostructur
lipid
carrier
staphylococcu
aureu
staphylococcu
epidermidi
escherichia
coli
nisin
z
exhibit
addit
interact
numer
convent
antibiot
particular
novobiocin
presenc
edta
improv
antimicrobi
activ
free
nisin
z
toward
escherichia
coli
significantli
nisin
zload
nlc
effect
gramposit
speci
physiolog
ph
also
show
increas
efficaci
ad
edta
nisin
zload
nlc
shown
potenti
enhanc
antibacteri
activ
nisin
z
toward
gramposit
bacteria
commonli
found
skin
infect
type
nanomateri
dendrim
carbon
nanodot
also
success
propos
deliveri
amp
due
eas
synthesi
low
manufactur
cost
antimicrobi
polym
includ
dendrim
exploit
mimic
antibacteri
mechan
host
defenc
peptid
compromis
bacteri
cell
membran
gide
et
al
develop
nanomaterialslipid
amphiphil
dendrim
display
potent
select
antimicrobi
activ
gramposit
gramneg
bacteria
includ
multidrugresist
strain
dendrim
also
shown
inhibit
bacteri
biofilm
effect
carbon
nanodot
carbon
quantum
dot
origin
discov
due
bright
fluoresc
emiss
found
convent
semiconductor
quantum
dot
also
use
drug
deliveri
carbon
dot
modifi
vancomycin
propos
treatment
gramposit
bacteri
infect
zhong
et
al
synthes
surfacemodifi
carbon
dot
vancomycin
success
test
bacillu
subtili
listeria
monocytogen
salmonella
pseudomona
aeruginosa
escherichia
coli
modifi
carbon
dot
show
affin
test
gramposit
bacteria
owe
interact
vancomycin
cell
wall
pramanik
et
al
synthesi
redblu
fluoresc
carbon
dotattach
magnet
nanoparticl
select
separ
identif
superbug
infect
blood
sampl
nanoparticl
capabl
isol
methicillinresist
staphylococcu
aureu
mrsa
salmonella
superbug
whole
blood
sampl
follow
accur
identif
via
multicolor
fluoresc
imag
author
also
describ
design
antimicrobi
peptideconjug
multicolor
fluoresc
magnetocarbon
dot
separ
identif
disinfect
multidrug
resist
superbug
infect
blood
amp
antimicrobi
compound
recogn
among
promis
drug
candid
infect
exhibit
distinct
mechan
action
may
show
addit
biolog
activ
eg
signal
molecul
biomark
even
tumoricid
agent
amp
howev
show
low
stabil
bioavail
formul
amp
nanomateri
seem
offer
appeal
effect
manner
improv
limit
sever
system
design
studi
purpos
eg
inorgan
polymer
lipid
nanoparticl
carbon
dot
dendrim
howev
concern
regul
distribut
nanomateri
bodi
specif
organ
also
rais
nanodrug
foreign
substanc
bodi
may
produc
inflamm
therefor
safeti
data
longterm
therapi
repeat
dosag
need
circumv
potenti
risk
biodegrad
nanomateri
propos
reduc
risk
toxicolog
event
vitro
vivo
date
studi
investig
toxicolog
environment
effect
direct
indirect
exposur
nanomateri
clear
guidelin
exist
quantifi
effect
therefor
urgent
need
develop
guidelin
assur
safe
use
nanomateri
moreov
power
ex
vivo
model
anim
model
need
assess
safeti
issu
compli
govern
regul
extend
shelf
life
nanodrug
also
problem
due
agglomer
also
problem
product
method
nanostructur
also
improv
scalabl
studi
industri
product
also
great
import
order
promot
cost
effect
new
formul
cost
product
nanomateri
larg
scale
one
hurdl
effect
implement
product
henc
scientif
commun
also
pay
attent
develop
afford
methodolog
nanotechnolog
reach
patient
conclus
seem
although
promis
research
result
area
rise
also
urgent
start
direct
effort
make
new
drug
formul
realiti
therapeut
agent
